Domo Inc logo

DOMO - Domo Inc News Story

$60.45 2.1  3.7%

Last Trade - 07/05/21

Sector
Technology
Size
Mid Cap
Market Cap £1.31bn
Enterprise Value £1.32bn
Revenue £151.4m
Position in Universe 2319th / 6850

U.S. RESEARCH ROUNDUP-NU Skin Enterprises, Rocket Pharmaceuticals, Washington REIT

Thu 2nd July, 2020 8:12am
July 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including NU Skin Enterprises, Rocket Pharmaceuticals and
Washington REIT, on Thursday. 
    
    HIGHLIGHTS
     * NU Skin Enterprises Inc  NUS.N : Jefferies raises to buy from hold
     * Rocket Pharmaceuticals Inc  RCKT.O : JP Morgan starts with overweight rating; PT $38
     * Washington REIT  WRE.N : JP Morgan raises to neutral from underweight
        
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday.
Stock entries are in alphabetical order.     
     * American Campus Communities Inc  ACC.N : Citigroup raises price target to $35 from $30
     * Api Group Corp  APG.N : Citigroup raises price target to $15 from $14
     * Atmos Energy Corp  ATO.N : Citigroup cuts price target to $107 from $125
     * Bank of America Corp  BAC.N : RBC cuts target price to $28 from $30
     * Calumet Specialty Products Partners LP  CLMT.O : Goldman Sachs cuts PT to $2.75 from $3
     * Constellation Brands Inc  STZ.N : Citigroup raises price target to $200 from $176
     * Constellation Brands Inc  STZ.N : Evercore ISI raises target price to $220 from $200
     * Constellation Brands Inc  STZ.N : Jefferies raises target price to $238 from $224
     * Corporate Office Properties Trust  OFC.N : JP raises to overweight from neutral
     * Corporate Office Properties Trust  OFC.N : JP raises target price to $29 from $26
     * CVR Energy Inc  CVI.N : Goldman Sachs cuts target price to $15 from $17
     * Delek US Holdings Inc  DK.N : Goldman Sachs cuts target price to $19 from $21
     * Docusign Inc  DOCU.O : RBC raises target price to $210 from $170
     * Domo Inc  DOMO.O : Cowen and Company raises target price to $42 from $36
     * Enterprise Products Partners LP  EPD.N : Citigroup cuts price target to $21 from $31
     * HollyFrontier Corp  HFC.N : Goldman Sachs cuts target price to $26 from $28
     * Independence Contract Drilling Inc  ICD.N : RBC cuts target price to $6 from $7
     * M&T Bank Corp  MTB.N : RBC cuts target price to $130 from $148
     * Marathon Petroleum Corp  MPC.N : Goldman Sachs cuts target price to $43 from $44
     * National Oilwell Varco Inc  NOV.N : Citigroup raises price target to $12 from $11.75
     * NiSource Inc  NI.N : Citigroup cuts price target to $24 from $29
     * NU Skin Enterprises Inc  NUS.N : Jefferies raises to buy from hold
     * NU Skin Enterprises Inc  NUS.N : Jefferies raises target price to $50 from $42
     * Par Pacific Holdings Inc  PARR.N : Goldman Sachs cuts target price to $12 from $13
     * Parsley Energy Inc  PE.N : RBC raises target price to $14 from $12
     * PBF Energy Inc  PBF.N : Goldman Sachs cuts target price to $9 from $10
     * Pebblebrook Hotel Trust  PEB.N : RBC cuts target price to $17 from $18
     * Phillips 66  PSX.N : Goldman Sachs cuts target price to $83 from $90
     * Rocket Pharmaceuticals Inc  RCKT.O : JP Morgan starts with overweight rating; PT $38
     * Tesla Inc  TSLA.O : Wedbush raises target price to $1,250 from $1,000
     * U.S. Bancorp  USB.N : RBC cuts target price to $42 from $48
     * Ultragenyx Pharmaceutical Inc  RARE.O : Citigroup raises price target to $72 from $66
     * Valero Energy Corp  VLO.N : Goldman Sachs cuts target price to $64 from $68
     * Washington REIT  WRE.N : JP Morgan raises to neutral from underweight
     * Washington REIT  WRE.N : JP Morgan raises target price to $24 from $22
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.